Content of the neurotoxins cycasin (methylazoxymethanol β‐D‐glucoside) and BNLAA (β‐N‐methylamino‐L‐alanine) in cycad flour prepared by Guam Chamorros

Exposure to cycad seed kernel is an etiologic factor for the western Pacific amyotrophic lateral sclerosis (ALS) and parkinsonism-dementia complex (PDC). Traditionally processed cycad flours (n = 17) obtained from Chamorro residents of Guam and the adjacent island of Rota at risk for neurodegenerative disease were extracted and analyzed by high-performance liquid chromatography for content of β-N-methylamino-L-alanine (BMAA) and methylazoxymethanol β-D-glucoside (cycasin). Cycasin (detection limit: picomole) was present in concentrations of 0.004 to 75.93 μg/g (mean, 12.45 ± 5.0 μg/g), and levels of BMAA (detection limit: subpicomole) ranged from 0.00 to 18.39 μg/g (mean, 5.44 ± 1.56 μg/g). On average, cycasin content was approximately 10 times higher than that of BMAA. The largest concentrations of cycasin were found in samples from villages with a high reported prevalence of ALS/PDC. Ingestion of cycad-derived food would result in estimated human exposure to milligram amounts of cycasin per day. The cytotoxic properties of cycasin merit consideration in relation to the etiology of western Pacific ALS/PDC.

[1]  V. Palmer,et al.  CYCAD USE AND MOTOR NEURONE DISEASE IN IRIAN JAYA , 1987, The Lancet.

[2]  P. Nunn,et al.  Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. , 1987, Science.

[3]  O. Mickelsen,et al.  Effects of methylazoxymethanol glucoside and methylazoxymethanol acetate on the cerebellum of the postnatal Swiss albino mouse. , 1972, Federation proceedings.

[4]  N. Mantel,et al.  Geographic patterns of parkinsonism-dementia complex on Guam. 1956 through 1985. , 1990, Archives of neurology.

[5]  D. Dastur,et al.  Effect of Boiling and Storing on Cycasin Content of Cycas circinalis L. , 1966, Nature.

[6]  C. Bergeron,et al.  β-N-Methylamino-l-alanine Chronic oral administration is not neurotoxic to mice , 1989, Journal of the Neurological Sciences.

[7]  E. Fiala,et al.  Non-alcohol dehydrogenase-mediated metabolism of methylazoxymethanol in the deer mouse, Peromyscus maniculatus. , 1984, Cancer research.

[8]  L. Kurland An appraisal of the neurotoxicity of cycad and the etiology of amyotrophic lateral sclerosis on Guam. , 1972, Federation proceedings.

[9]  R. Adamson,et al.  Carcinogenicity and hepatotoxicity of cycasin and its aglycone methylazoxymethanol acetate in nonhuman primates. , 1980, Journal of the National Cancer Institute.

[10]  J. Cavanagh,et al.  Selective degeneration of cerebellar cortical neurons caused by cycad neurotoxin, L‐β‐methylaminoalanine (L‐BMAA), in rats , 1990, Neuropathology and applied neurobiology.

[11]  D. Dastur,et al.  The experimental pathology of cycad toxicity with special reference to oncogenic effects. , 1974, Indian Journal of Cancer.

[12]  D. Dastur CYCAD TOXICITY IN MONKEYS: CLINICAL, PATHOLOGICAL, AND BIOCHEMICAL ASPECTS. , 1964, Federation proceedings.

[13]  F. Nicoletti,et al.  Beta-N-methylamino-L-alanine (L-BMAA) is a potent agonist of 'metabolotropic' glutamate receptors. , 1990, European journal of pharmacology.

[14]  P. Nunn,et al.  Carbamate formation and the neurotoxicity of L-alpha amino acids. , 1991, Science.

[15]  K. Tadera,et al.  Hepatic and spinal lesions in goats chronically intoxicated with cycasin. , 1986, Nihon juigaku zasshi. The Japanese journal of veterinary science.

[16]  A. Kobayashi Cycasin in cycad materials used in Japan. , 1972, Federation proceedings.